Molecular Signal Reception in Complex Vessel Networks: The Role of the Network Topology
Timo Jakumeit, Lukas Brand, Jens Kirchner, Robert Schober, and, Sebastian Lotter

TL;DR
This paper develops an analytical model to understand how the topology of complex vessel networks affects molecular signal reception, with applications in medical diagnostics and targeted drug delivery within the human cardiovascular system.
Contribution
It introduces a generic end-to-end model for molecule propagation in branched vessel networks, specialized for SPION-based MC systems, and links network topology to signal quality metrics.
Findings
Validated the model with testbed data.
Proposed metrics for network-induced molecule dispersion.
Linked network topology to SNR at target locations.
Abstract
The notion of synthetic molecular communication (MC) refers to the transmission of information via molecules and is largely foreseen for use within the human body, where traditional electromagnetic wave (EM)-based communication is impractical. MC is anticipated to enable innovative medical applications, such as early-stage tumor detection, targeted drug delivery, and holistic approaches like the Internet of Bio-Nano Things (IoBNT). Many of these applications involve parts of the human cardiovascular system (CVS), here referred to as networks, posing challenges for MC due to their complex, highly branched vessel structures. To gain a better understanding of how the topology of such branched vessel networks affects the reception of a molecular signal at a target location, e.g., the network outlet, we present a generic analytical end-to-end model that characterizes molecule propagation and…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsMolecular Communication and Nanonetworks · Photoreceptor and optogenetics research · Computational Drug Discovery Methods
